NCT00116324View on ClinicalTrials.gov

Predicting the Response to Montelukast by Genetic Variation in Asthmatics

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

December 31, 2006

Conditions
Asthma
Interventions
DRUG

Montelukast

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT00116324 - Predicting the Response to Montelukast by Genetic Variation in Asthmatics | Biotech Hunter | Biotech Hunter